THE WHAT? Beiersdorf reported Group sales of €9.9 billion in 2025, representing organic growth of 2.4%, with Derma and Health Care driving performance despite a slowing global skin care market.
THE DETAILS Consumer Business sales reached €8.2 billion (+2.5% organic), supported by Derma growth of 11.7%—its fifth consecutive year of double-digit gains—and Health Care growth of 9.3%. NIVEA grew 0.9% to €5.5 billion amid market slowdown and restructuring in China, while La Prairie declined 4.5% to €478 million but returned to growth in the fourth quarter.
EBIT excluding special factors rose to €1.4 billion, lifting the margin slightly to 14.0% (2024: 13.9%). tesa generated €1.7 billion in sales (+1.8% organic) in a challenging environment. The company proposed a dividend of €1.00 per share and announced a new share buyback program of up to €750 million over the next two years. For 2026, Beiersdorf expects flat to slightly growing organic sales and an EBIT margin slightly below 2025 levels.
THE WHY? The results reflect Beiersdorf’s ability to outperform the broader skin care market through strong innovation in Derma and disciplined cost management, while recalibrating NIVEA’s strategy to restore momentum amid ongoing market volatility.
Source: Beiersdorf
